Takeda Pharmaceutical Company and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, have entered a multi-year collaboration to advance breakthrough therapeutic discoveries in rare diseases.

The collaboration will leverage on Harrington Discovery Institute’s established operating model to create a new programme to advance the development of medicines for rare diseases.

The partnership is also expected to upgrade Takeda’s strategic R&D focus in its therapeutic areas of oncology, gastroenterology and central nervous system disorders.

The Harrington programme will assist MD and PhD researchers from the US to carry out disruptive and transformative research, which will help with developing new treatments.

Takeda centre for external innovation head Daniel Curran said: “This collaboration is another example of how Takeda is focused on fostering partnerships between academia and industry and its increasing commitment to the development of medicines in rare diseases, particularly in our therapeutic areas of focus in oncology, gastroenterology and central nervous system disorders.

"Our collaboration demonstrates a new way of business that is driven by a shared vision and mission."

“We believe Harrington Discovery Institute has a unique structure that is immensely helpful to academic researchers who are developing novel therapeutics that can result in a significant impact for patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Our collaboration demonstrates a new way of business that is driven by a shared vision and mission.”

Researchers of this new programme will have access to funding from the Harrington Discovery Institute and learn drug development capability and project management from Innovation Support Center experts.

Furthermore, the researchers will also have access to Takeda’s internal research and development experts.

The Harrington Discovery Institute at University Hospitals, part of The Harrington Project for Discovery and Development, focuses on advancing medicinal development by assisting the scientists with evolving their discoveries into medicines.

The institute was created in 2012 with a $50m funding from the Harrington family.